Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)

J Antimicrob Chemother. 2020 Sep 1;75(9):2700-2702. doi: 10.1093/jac/dkaa231.

Authors

S Nozza¹, R Ferrarese¹, A Poli¹, L Galli¹, M Sampaolo¹, A Bigoloni¹, A Galli¹, C Muccini², V Spagnuolo², A Lazzarin^{1

2}, M Clementi^{1

2}, N Mancini^{1

2}, A Castagna^{1

2}

Affiliations

¹ San Raffaele Scientific Institute, Milan, Italy.
² University Vita-Salute San Raffaele, Milan, Italy.

PMID: 32542322
DOI: 10.1093/jac/dkaa231

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

APACHE
Anti-HIV Agents* / therapeutic use
Antiretroviral Therapy, Highly Active
CD4 Lymphocyte Count
HIV Infections* / drug therapy
Humans
Microbiota*
Viral Load

Substances

Anti-HIV Agents